Mcgowan Institute For Regenerative Medicine

RMT Podcast #54 – Thomas Tillet

Informações:

Sinopse

Regenerative Medicine Today welcomes Thomas Tillett, who is the founding President and CEO of RheoGene. Under Mr. Tillett’s leadership, RheoGene established an innovative clinical development program with the RheoSwitch ™ Therapeutic System that has led to the first human clinical trial of a small molecule induced gene regulation system. A Phase I clinical [...]